Niceritrol
From Wikipedia, the free encyclopedia
|
Niceritrol
|
|
| Systematic (IUPAC) name | |
| [3-(pyridine-3-carbonyloxy)-2,2-bis(pyridine-3-carbonyloxymethyl)propyl] pyridine-3-carboxylate | |
| Identifiers | |
| CAS number | ? |
| ATC code | C10 |
| PubChem | |
| Chemical data | |
| Formula | C29H24N4O8 |
| Mol. mass | 556.523 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Niceritrol is a niacin derivative used as a hypolipidemic agent.
|
||||||||||||||||||||||||||

